...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ZHCLF up 290% to $0.16...question
1
Dec 14, 2020 01:50PM

KOO - Still clears nothing up. We already knew that ZHCLF has been assigned to ZCC Calgary so no surprise that Calgary info. comes up for it. What we don't know is whether or not it has also been assigned to ZCC Vancouver. Both companies say they don't trade OTC so that tells nothing either. 

Share
New Message
Please login to post a reply